Gabapentin Extended-Release Tablets Should Not Be Cut
Extended-release (ER) formulations of gabapentin should not be cut, crushed, or chewed as this would compromise their controlled-release mechanism and potentially lead to dose dumping, increasing the risk of adverse effects. 1
Understanding Extended-Release Gabapentin Formulations
Extended-release formulations of gabapentin are specifically designed to:
- Release medication gradually over a prolonged period
- Maintain more consistent blood levels
- Allow for less frequent dosing (typically once or twice daily instead of three times daily)
- Potentially reduce side effects associated with peak concentrations
Pharmacokinetic Considerations
The FDA-approved gabapentin label clearly indicates that extended-release formulations have specific properties that would be compromised if the tablet is altered:
- For scored tablets (600 mg or 800 mg), the immediate-release formulation can be divided, but unused half-tablets should be taken as the next dose and not stored beyond 28 days 1
- Extended-release formulations rely on polymer technology that controls drug release through gradual swelling and retention in the gastrointestinal tract 2
- Altering the tablet would disrupt this mechanism, potentially causing dose dumping and increasing the risk of adverse effects
Clinical Implications of Cutting ER Tablets
Cutting extended-release gabapentin tablets would:
- Destroy the controlled-release mechanism
- Potentially release a higher dose than intended in a shorter timeframe
- Increase risk of adverse effects such as:
- Dizziness
- Somnolence
- Ataxia
- Peripheral edema
Alternative Options for Dosing
For patients who need dose adjustments or have difficulty swallowing whole tablets:
- Use immediate-release gabapentin formulations which are available in multiple strengths (100 mg, 300 mg, 400 mg, 600 mg, 800 mg) for more flexible dosing 1
- For immediate-release formulations, scored tablets can be divided as needed 1
- Consider gabapentin oral solution for patients with swallowing difficulties 3
Special Considerations for Elderly Patients
The elderly population requires particular attention when using extended-release formulations:
- Elderly patients are more sensitive to both pharmacological and toxicological effects of medications 3
- Extended-release formulations of antiepileptic drugs may be better tolerated than immediate-release equivalents, but cannot be altered 3
- For elderly patients with swallowing difficulties, immediate-release formulations or oral solutions are preferred over cutting extended-release tablets 3
Conclusion
Extended-release gabapentin tablets must be taken whole to maintain their intended pharmacokinetic profile and therapeutic effect. Cutting these tablets would compromise their controlled-release properties and potentially lead to adverse effects. For patients requiring dose adjustments or who have difficulty swallowing, immediate-release formulations offer more flexibility in dosing and administration.